source
- Amgen and AbbVie report Inflation Reduction Act negotiations dent Q1 salesAmgen and AbbVie disclosed in their first-quarter earnings that the Inflation Reduction Act is already affecting their sales. The companies said the first set of drug-price negotiations required b…
- Madrigal's Rezdiffra sales top forecasts as Gilead announces job cutsMadrigal Pharmaceuticals reported first‑quarter sales of its MASH drug Rezdiffra at $311 million, roughly $10 million above analyst expectations, according to TD Cowen. The outperformance highligh…